These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10707445)

  • 41. Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient.
    Agarwal SK; Gupta S; Dash SC; Bhowmik D; Tiwari SC
    Int Urol Nephrol; 2004; 36(3):425-31. PubMed ID: 15783119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):327-45. PubMed ID: 8000420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isoniazid-induced neuropathy in a pre-pubertal child.
    Shetty NS; Shah I
    Paediatr Int Child Health; 2019 Aug; 39(3):216-218. PubMed ID: 29897291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Follow-up results of isoniazid chemoprophylaxis during biological therapy in Colombia.
    Cataño JC; Morales M
    Rheumatol Int; 2015 Sep; 35(9):1549-53. PubMed ID: 25763992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of interstitial pneumonia in a patient with rheumatoid arthritis induced by isoniazid for tuberculosis chemoprophylaxis.
    Migita K; Umeno T; Miyagawa K; Izumi Y; Sasaki E; Kakugawa T; Ito M; Kinoshita A; Miyashita T
    Rheumatol Int; 2012 May; 32(5):1375-7. PubMed ID: 20349068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
    Gordin F; Chaisson RE; Matts JP; Miller C; de Lourdes Garcia M; Hafner R; Valdespino JL; Coberly J; Schechter M; Klukowicz AJ; Barry MA; O'Brien RJ
    JAMA; 2000 Mar; 283(11):1445-50. PubMed ID: 10732934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of blended treatment literacy and psychoeducation on methadone maintenance treatment outcomes in Yunnan, China.
    Zhang B; Cai T; Yan Z; Mburu G; Wang B; Yang L
    Harm Reduct J; 2016 Feb; 13():8. PubMed ID: 26915361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence.
    Mitchell TB; White JM; Somogyi AA; Bochner F
    Addiction; 2004 Aug; 99(8):940-5. PubMed ID: 15265090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Divided doses for methadone maintenance.
    Modesto-Lowe V
    Am J Psychiatry; 2008 Oct; 165(10):1358; author reply 1358-9. PubMed ID: 18829892
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effectiveness of isoniazid inhalation in patients with endobronchial tuberculosis].
    Miki K; Yokota S; Hiraga T; Yamaguchi T; Nakagawa M; Maekura R; Ito M; Ogura T
    Nihon Kokyuki Gakkai Zasshi; 1999 Jan; 37(1):31-5. PubMed ID: 10087873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical study on the cases in which INH or RFP was discontinued during treatment for pulmonary tuberculosis].
    Harada S; Takamoto M; Ishibashi T; Mohri M; Sato K; Yamagishi F; Sasaki Y; Tanabe K; Sato R; Fujino T; Tano M; Tanizawa M; Sakatani M; Morimoto T; Kawahara S; Hotta N; Shigeto E; Nishimura K; Abe T; Iwanaga T; Oe T; Shimazu K; Ebihara M; Nakagawa S; Kuba M;
    Kekkaku; 2001 May; 76(5):427-36. PubMed ID: 11449698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of isoniazid chemoprophylaxis in renal transplant recipients.
    Naqvi R; Naqvi A; Akhtar S; Ahmed E; Noor H; Saeed T; Akhtar F; Rizvi A
    Nephrol Dial Transplant; 2010 Feb; 25(2):634-7. PubMed ID: 19783599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.
    Samandari T; Agizew TB; Nyirenda S; Tedla Z; Sibanda T; Shang N; Mosimaneotsile B; Motsamai OI; Bozeman L; Davis MK; Talbot EA; Moeti TL; Moffat HJ; Kilmarx PH; Castro KG; Wells CD
    Lancet; 2011 May; 377(9777):1588-98. PubMed ID: 21492926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Compliance with anti-tuberculosis preventive therapy among 6-year-old children.
    Alperstein G; Morgan KR; Mills K; Daniels L
    Aust N Z J Public Health; 1998 Apr; 22(2):210-3. PubMed ID: 9744178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A simplified method for detecting isoniazid compliance in patients receiving antituberculosis chemotherapy.
    Hashiguchi M; Ohno K; Sakuma A; Hino F; Tanaka T; Ohtsuji M; Matsumoto N; Yanase K; Urae A; Hosogai Y; Sato N; Yazaki A; Matsuda K; Yamazaki K; Rikihisa T
    J Clin Pharmacol; 2002 Feb; 42(2):151-6. PubMed ID: 11831537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection.
    Eidlitz-Markus T; Zeharia A; Baum G; Mimouni M; Amir J
    Chest; 2003 Mar; 123(3):736-9. PubMed ID: 12628871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children.
    Ramachandran G; Hemanth Kumar AK; Bhavani PK; Poorana Gangadevi N; Sekar L; Vijayasekaran D; Banu Rekha VV; Ramesh Kumar S; Ravichandran N; Mathevan G; Swaminathan S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):800-6. PubMed ID: 23676165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis.
    Katiyar SK; Bihari S; Prakash S; Mamtani M; Kulkarni H
    Int J Tuberc Lung Dis; 2008 Feb; 12(2):139-45. PubMed ID: 18230245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha.
    Hanta I; Ozbek S; Kuleci S; Sert M; Kocabas A
    Clin Rheumatol; 2007 Nov; 26(11):1867-70. PubMed ID: 17332973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.